Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitus
- 期刊名称Reactions Weekly
- 卷第1206卷
- 期第1期
- 印刷ISSN0114-9954
- 电子ISSN1179-2051
- 文件大小133.24KB
- 发表时间2008-06
- DOI10.2165/00128415-200812060-00016
The Netherlands Pharmacovigilance Centre Lareb has received 37 reports of depression associated with bupropionReactions Weekly · 2007
The Netherlands Pharmacovigilance Centre Lareb has received five reports of fixed drug eruption associated with fluconazole capsulesReactions Weekly · 2008
The Netherlands Pharmacovigilance Centre Lareb has received five reports of dental caries associated with the use of salbutamolReactions Weekly · 2008
The Netherlands Pharmacovigilance Centre Lareb has received four reports, concerning two events, of anaphylactic reactions associated with fluorescein useReactions Weekly · 2008
The Netherlands Pharmacovigilance Centre Lareb has received three reports* of seizures associated with domperidone use up to 4 January 2008;Reactions Weekly · 2008
The Netherlands Pharmacovigilance Centre Lareb has received seven reports of arthralgia associated with the use of cetirizine [Zyrtec] or levocetirizine [Xyzal]Reactions Weekly · 2008
The Netherlands Pharmacovigilance Centre Lareb has received five reports of psychiatric disorders associated with use of goserelin (n = 4) or buserelin (1)Reactions Weekly · 2007
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991